Celestial Biolabs Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Mar 2018
Auditor and Management Disclosures and Notes for the annual results dated 31 Mar 2018
1) The Statement has been reviewed by the Audit Committee and approved by the Board of Directors at it's meeting held on 30.05.2018
2) The Statutory Auditors have carried out a Audit of the Financial results for the quarter/ year ended 31st March,2018 prescribed under Section 133 of the Companies Act,2013 and other recognised accounting practices and policies to the extent applicable. Beginning April, 1, 2017 the Company has for the first time adopted Ind AS with a transition date of April,1, 2017.
3) The Company is engaged in the business of "Herbal Products" and therefore, has only one reportable segment in accordance with Ind AS 108 " Operating Segment". 4) The Statement does not include Ind AS Complaint results for the preceding quarter and previous year ended March 31,2017 as the same is not Mandatory as per SEBI's circular dated July 5, 2016.
5) The Financial results and other financial information for the quarter ended 31st March,2017 has been compiled by the management as per Ind AS, after exercising necessary due deligence , to ensure that the financial results provide true and fair view of the results in accordance with Ind AS. This information has not been subject to any limited review or audit.
6) Reconciliation of Profit between Ind-AS and Indian GAAP for the quarter ended 31st March,2017 is as follows: